Opioid Harm Mitigation Strategies+ Opioid Desensitization and Neurorestoration Framework

Baseline (Prevention)

Opioids include synthetic and semi-synthetic drugs like fentanyl, oxycodone, and methadone. Opiates refer to natural alkaloids from opium: morphine, codeine, and thebaine.
To prevent tolerance:

  • Rotate compounds (e.g., morphine ↔ hydromorphone)

  • Use the lowest effective dose

  • Introduce NMDA antagonists like low-dose ketamine or memantine intermittently


Active Tachyphylaxis

Once tachyphylaxis is active:

  • Rotate to a lower cross-tolerance compound (e.g., switch from oxycodone to tapentadol or levorphanol)

  • Add NMDA antagonists daily for a week

  • Consider low-dose ibogaine or mitragynine (kratom alkaloid) cautiously for receptor reset

  • Microdosed naltrexone (0.5–1 mg) may paradoxically upregulate MOR sensitivity


Withdrawal Transition

  • Initiate a taper or switch to a partial agonist (buprenorphine) or weak full agonist (tramadol)

  • Introduce clonidine or lofexidine to manage adrenergic rebound

  • Use gabapentin, L-theanine, and magnesium to reduce somatic hyperexcitability


Neurorestoration Phase

  • Support the endogenous endorphin system with:

    • Cold exposure

    • Aerobic activity

    • Adaptogens (e.g., rhodiola)

  • Supplement with DLPA (DL-phenylalanine) to inhibit enkephalinase

  • Use N-acetylcysteine to support glutamate homeostasis

  • Explore low-dose naltrexone cycling (3–5 mg/day) for opioid receptor density recalibration


Maintenance / Reinforcement

  • Avoid recreational opioid reuse

  • For pain management, rotate to kappa agonists or biased ligands (e.g., cebranopadol, when available)

  • Reinforce dopaminergic and serotonergic tone through non-opioid hedonic pathways:

    • Oxytocin, music, social bonding

  • Keep NMDA antagonists on hand (PRN)